Texas Capital Bancshares, Inc. (TCBIO) is a Banks - Regional company in the Financial Services sector, currently trading at $21.96. It has a SharesGrow Score of 69/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of TCBIO = $130.66 (+495% from the current price, the stock appears undervalued).
Valuation: TCBIO trades at a trailing Price-to-Earnings (P/E) of 13.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.12.
Financials: revenue is $2.0B, +18.6%/yr average growth. Net income is $330M, growing at +74.6%/yr. Net profit margin is 16.5% (healthy). Gross margin is 60.6% (-12.5 pp trend).
Balance sheet: total debt is $951M against $3.6B equity (Debt-to-Equity (D/E) ratio 0.26, conservative). Current ratio is 12.58 (strong liquidity). Debt-to-assets is 3%. Total assets: $31.5B.
Analyst outlook: 7 / 26 analysts rate TCBIO as buy (27%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 77/100 (Pass), Growth 90/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 59/100 (Partial), Future 20/100 (Fail), Income 70/100 (Pass).
